Login
$NEOG
$10.88 -$0.35 (3.12%) Live

$NEOG SEC Filings

Filed On Filing
04 Nov 2026 Form 4: Yarwood Jeremy, Chief Scientific Officer

Received 16,207 shares by exercise or conversion ($192K) · Gave up 7,156 shares to cover exercise price or tax ($84.6K) · Sold 9,051 shares ($115K)

04 Nov 2026 8-K: Other Events

On March 2, 2026, Neogen Corporation (“Neogen”) announced that it had entered into a definitive agreement to sell its global Genomics business to Zoetis Inc. (“Zoetis”). This transaction is subject to customary closing conditions and reg...

04 Nov 2026 144
03 Nov 2026 Form 4: Freels Joe B, Chief Commercial Officer

Received 6,345 shares as a grant or award ($75K) · Granted 31,311 Common Stock (Right to Buy)

30 Oct 2026 Form 4: Hastings Gregory S, VP, Animal Health

Received 1,211 shares by exercise or conversion ($14.8K) · Gave up 337 shares to cover exercise price or tax ($4.11K)

30 Oct 2026 Form 4: Woteki Catherine E, Director

Received 1,776 shares by exercise or conversion ($21.7K)

30 Oct 2026 Form 4: Rodriguez Rafael A, Director

Received 1,776 shares by exercise or conversion ($21.7K)

30 Oct 2026 Form 3: Burke Kevin M, Chief HR Officer

Holds 12,929 shares of Common Stock

30 Oct 2026 Form 4: Gupta Aashima, Director

Received 1,776 shares by exercise or conversion ($21.7K)

30 Oct 2026 Form 4: Green Ronald D, Director

Received 1,776 shares by exercise or conversion ($21.7K)

30 Oct 2026 Form 4: Capello Jeffrey D, Director

Received 1,776 shares by exercise or conversion ($21.7K)

30 Oct 2026 Form 4: Borel James C, Director

Received 1,776 shares by exercise or conversion ($21.7K)

28 Oct 2026 144
26 Oct 2026 8-K/A: Departure/Election of Directors or Officers; Compensation

At the annual meeting of shareholders of Neogen Corporation (the “Company”) held on October 1, 2026, the Company’s shareholders approved the Neogen Corporation Amended and Restated Omnibus Incentive Plan (the “Plan”). The Plan is an amen...

23 Oct 2026 Form 4: Hastings Gregory S, VP, Animal Health

Received 287 shares by exercise or conversion ($3.44K) · Gave up 80 shares to cover exercise price or tax ($960)

23 Oct 2026 Form 3: Hastings Gregory S, VP, Animal Health

Holds 32,368 shares of Common Stock

21 Oct 2026 Form 3: Walter James A, SVP of Manufacturing

Holds 28,955 shares of Common Stock

21 Oct 2026 Form 3: Yarwood Jeremy, Chief Scientific Officer

Holds 297 shares of Common Stock

21 Oct 2026 Form 3: Freels Joe B, Chief Commercial Officer

No securities owned

20 Oct 2026 S-8

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support